Okay, let's tackle this question. The patient has primary biliary cirrhosis (PBC), which is now called primary biliary cholangitis. The key here is that the question is asking for a treatment that can "cure" PBC. The options aren't given, but I need to figure out the correct answer based on standard treatments.

First, the core concept: PBC is an autoimmune liver disease where the immune system attacks the small bile ducts. This leads to cholestasis, which causes pruritus and other symptoms. The progression can lead to cirrhosis and liver failure. Now, the treatment options. The standard is ursodeoxycholic acid (UDCA), which is a bile acid that helps with the disease progression. But does it cure PBC? No, UDCA is a disease-modifying agent, not a cure. It slows progression but doesn't reverse the disease.

Then there's obeticholic acid (OCA), which is another medication used when UDCA isn't effective. Again, not a cure. So, the only treatment that can actually cure PBC is liver transplantation. When the liver is so damaged that it can't function, a transplant replaces the diseased liver with a healthy one. That's the only curative option. The other treatments manage symptoms or slow progression but don't eliminate the disease.

Looking at possible wrong options, maybe options like UDCA, OCA, or even cholestyramine (which treats pruritus) are distractors. The clinical pearl here is that liver transplant is the only cure for end-stage liver disease from PBC. So the correct answer must be the one that refers to liver transplantation.

**Core Concept** The question tests knowledge of definitive treatment for end-stage primary biliary cholangitis (PBC), an autoimmune cholestatic liver disease. **Curative** interventions for PBC are limited to irreversible therapies like liver transplantation, as medical management only slows progression.

**Why the Correct Answer is Right** Liver transplantation is the only treatment that can "cure" PBC by replacing the diseased liver with a healthy graft. It addresses the underlying pathophysiology of bile duct destruction and fibrosis, which cannot be reversed by pharmacologic agents. Post-transplant survival rates are high (5-year survival >85%), and recurrence in the transplanted liver is rare due to immunosuppressive therapy suppressing the autoimmune process.

**Why Each Wrong Option is Incorrect**
**Option A:** Ursodeoxycholic acid (UDCA) is first-line therapy but **slows disease progression** rather than curing it.
**Option B:** Obeticholic acid (OCA) is used for UDCA-ineffective patients but remains a **disease-modifying** agent.
**Option C:** Cholestyramine treats pruritus symptomatically but has **no effect on underlying disease**.

**Clinical Pearl / High-Yield Fact** Remember: **"Only a liver transplant cures PBC."** Medical therapies (UDCA, OCA) are **not curative**—they delay liver failure and reduce mortality but require lifelong use. Confusing "symptomatic relief" (e.g., cholestyramine) with "curative intent" is a common exam trap.

**Correct Answer: D. Liver transplantation**

✓ Correct Answer: D. liver transplantation